Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Timur Ivannikov is an analyst at Raymond James. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/06/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
03/07/2023 | GOSS | Buy Now | Gossamer Bio | $1.26 | 296.83% | Timur Ivannikov30% | → $5 | Downgrade | Outperform → Market Perform | Get Alert |
01/06/2023 | ANAB | Buy Now | AnaptysBio | $20.73 | — | Timur Ivannikov30% | — | Downgrade | Outperform → Market Perform | Get Alert |
07/08/2022 | RCKT | Buy Now | Rocket Pharmaceuticals | $7.85 | 180.25% | Timur Ivannikov30% | → $22 | Initiates | → Outperform | Get Alert |
04/18/2022 | GOSS | Buy Now | Gossamer Bio | $1.26 | 1407.94% | Timur Ivannikov30% | → $19 | Initiates | → Outperform | Get Alert |
03/01/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $19.98 | 470.57% | Timur Ivannikov30% | $112 → $114 | Maintains | Strong Buy | Get Alert |
11/15/2021 | CBIO | Buy Now | Catalyst Biosciences | — | — | Timur Ivannikov30% | — | Downgrade | Outperform → Market Perform | Get Alert |
04/29/2021 | CBIO | Buy Now | Catalyst Biosciences | — | — | Timur Ivannikov30% | $18 → $19 | Maintains | Outperform | Get Alert |
04/01/2021 | NEXI | Buy Now | NexImmune | $0.00 | 29999900% | Timur Ivannikov30% | → $30 | Initiates | → Outperform | Get Alert |